60 Day FRN

62398

Federal Register / Vol. 88, No. 174 / Monday, September 11, 2023 / Notices

substance in schedule IV or V which is
also listed in schedule I or II of the
Convention on Psychotropic
Substances, must have an import
permit. To obtain the permit to import
controlled substances for domestic and
or scientific purposes, an application for
the permit must be made to the DEA, on
DEA Form 357.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a previously approved
collection.
2. The Title of the Form/Collection:
Application for Permit to Import

Controlled Substances for Domestic
and/or Scientific Purposes.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form 357. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as the
obligation to respond: Affected Public:
Private Sector—businesses or other forprofit institutions. The obligation to
respond is mandatory per 21 CFR,
sections 1312.11, 1312.12 and 1312.13.

5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that 124
registrants participate in this
information collection. The time per
response is 21 minutes to complete the
DEA–357 (paper) and 15 minutes to
complete DEA–357 (online).
6. An estimate of the total annual
burden (in hours) associated with the
collection: DEA estimates that this
collection takes 264.35 annual burden
hours.
7. An estimate of the total annual cost
burden associated with the collection, if
applicable: $0.

TOTAL BURDEN HOURS
Number of
respondents

Activity

Time per
response
(min.)

Total annual
burden
(hours)

DEA Form: 357 (online) .......................................................
DEA Form: 357 (paper) .......................................................

124

9

958
71

15
21

266
19

Unduplicated Totals ......................................................

124

........................

1,081

0.26

264.35

If additional information is required
contact: Darwin Arceo, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 4W–218,
Washington, DC.
Dated: September 5, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2023–19536 Filed 9–8–23; 8:45 am]
BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE
[OMB Number 1117–0024]

Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Revision of a
Previously Approved Collection;
Report of Loss or Disappearance of
Listed Chemicals and Regulated
Transactions in Tableting/
Encapsulating Machines
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
ddrumheller on DSK120RN23PROD with NOTICES1

Total annual
responses

Frequency

The Drug Enforcement
Administration (DEA), Department of
Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in

SUMMARY:

VerDate Sep<11>2014

17:10 Sep 08, 2023

Jkt 259001

accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
November 13, 2023.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott A Brinks, Regulatory Drafting and
Policy Support Section, Drug
Enforcement Administration; Mailing
Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone:
(571) 362–3261, Email: scott.a.brinks@
dea.gov.
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;

SUPPLEMENTARY INFORMATION:

PO 00000

Frm 00084

Fmt 4703

Sfmt 4703

—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Abstract: Each regulated person is
required to report any unusual or
excessive loss or disappearance of a
listed chemical, and any regulated
transaction in a tableting or
encapsulating machine, to include any
domestic regulated transaction in a
tableting or encapsulating machine and
any import or export of a tableting or
encapsulating machine. 21 U.S.C. 830
(b)(1)(A), (C) and (D); 21 CFR
1310.05(a)(1), (3)–(4); 21 CFR
1310.05(c). Regulated persons include
manufacturers, distributors, importers,
and exporters of listed chemicals,
tableting machines, or encapsulating
machines, or persons who serve as
brokers or traders for international
transactions involving a listed chemical,
tableting machine, or encapsulating
machine. 21 CFR 1300.02(b). This report
will be submitted electronically. DEA
will be modifying this collection (1117–
0024) and collection 1117–0001 by
removing Form 107 from this collection
and adding it to 1117–0001 because

E:\FR\FM\11SEN1.SGM

11SEN1

62399

Federal Register / Vol. 88, No. 174 / Monday, September 11, 2023 / Notices
DEA Form 107 is more aligned with
DEA Form 106 (which is approved
under 1117–0001).
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a previously approved
collection.
2. The Title of the Form/Collection:
Report of Loss or Disappearance of
Listed Chemicals and Regulated
Transactions in Tableting/Encapsulating
Machines.
3. The agency form number, if any,
and the applicable component of the

Department sponsoring the collection:
DEA Form 452. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as the
obligation to respond: Affected Public
(Primary): Private Sector—businesses or
other for-profit institutions, and not-forprofit institutions. Other: State, local
and tribal governments, Federal
Government. The obligation to respond
is mandatory per 21 21 CFR

1310.05(a)(1), (3)–(4); 21 CFR
1310.05(c).
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that 274
persons respond as needed to this
collection. Responses take 0.33 minutes.
6. An estimate of the total annual
burden (in hours) associated with the
collection: DEA estimates that this
collection takes 8,367 annual burden
hours.
7. An estimate of the total annual cost
burden associated with the collection, if
applicable: $0.

TOTAL BURDEN HOURS
Number of
respondents

Activity

Total annual
responses

Time per
response
(mins)

Total annual
burden
(hours)

DEA–452 ..............................................................................

274

92

25,208

.33

8,367

Unduplicated Totals ......................................................

274

........................

25,101

........................

8,367

If additional information is required
contact: Darwin Arceo, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 4W–218,
Washington, DC.
Dated: September 5, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2023–19538 Filed 9–8–23; 8:45 am]
BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Previously Approved Collection;
Application for Permit To Export
Controlled Substances, Application for
Permit To Export Controlled
Substances for Subsequent Reexport
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:

The Drug Enforcement
Administration (DEA), Department of
Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.

SUMMARY:

VerDate Sep<11>2014

18:16 Sep 08, 2023

Comments are encouraged and
will be accepted for 60 days until
November 13, 2023.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott A. Brinks, Regulatory Drafting and
Policy Support Section, Drug
Enforcement Administration; Mailing
Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone:
(571) 362–3261, Email: scott.a.brinks@
dea.gov.
DATES:

Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and

SUPPLEMENTARY INFORMATION:

[OMB Number 1117–0004]

ddrumheller on DSK120RN23PROD with NOTICES1

Frequency

Jkt 259001

PO 00000

Frm 00085

Fmt 4703

Sfmt 4703

—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Abstract: Title 21, Code of Federal
Regulations (21 CFR), sections 1312.21
and 1312.22 require that any person
who desires to export or reexport
controlled substances listed in
schedules I or II, any narcotic substance
listed in schedules III or IV, or any nonnarcotic substance in schedule III which
the Administrator has specifically
designated by regulation in section
1312.30, or any non-narcotic substance
in schedule IV or V which is also listed
in schedule I or II of the Convention on
Psychotropic Substances, must have an
export permit.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a previously approved
collection.
2. The Title of the Form/Collection:
Application for Permit to Export
Controlled Substances, Application for
Permit to Export Controlled Substances
for Subsequent Reexport.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Forms: 161, 161R, and 161R–EEA.
The applicable component within the
Department of Justice is the Drug

E:\FR\FM\11SEN1.SGM

11SEN1